Mavacamten treatment in obstructive hypertrophic cardiomyopathy for up to 30 weeks: An integrated analysis of cardiac magnetic resonance data from a diverse population in randomized clinical trials
31 August 2025 (17:30 - 17:40)
Organised by: 
About the speaker
University of Virginia, Charlottesville (United States of America)
7 More presentations in this session
Doctor S. Schoonvelde (Rotterdam, NL)
Professor Y. Cui (Hangzhou, CN)
Access the full session
The Event
ESC Congress 2025
31 August 2025
17:30 CET
You may be interested in
Congress Session
Congress Session
